These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17348867)

  • 1. The value of Good Manufacturing Practice to a Blood Service in managing the delivery of quality.
    Slopecki A; Smith K; Moore S
    Vox Sang; 2007 Apr; 92(3):187-96. PubMed ID: 17348867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMP in blood collection and processing.
    Wagstaff W
    Vox Sang; 1998; 74 Suppl 2():513-21. PubMed ID: 9704492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quest for quality blood banking program in the new millennium the American way.
    Kim DU
    Int J Hematol; 2002 Aug; 76 Suppl 2():258-62. PubMed ID: 12430934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report on the activity of the blood bank accreditation program (1987-1995)].
    Pinto V; Algora M; Blanco L; Carpio N; Cortés A; Muñiz E; Oyonarte S; Puig L; Rodríguez J; Vesga MA
    Sangre (Barc); 1998 Jun; 43(3):196-201. PubMed ID: 9741225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transposition of the Blood Directive into national law--the perspective of Portugal.
    Gonçalves MH; Muon MC; Gonçalves Jd
    Transfus Clin Biol; 2005 Feb; 12(1):18-20. PubMed ID: 15814287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance, quality control and accreditation.
    Engelfriet CP; Reesink HW; de Lange GG; Flanagan P; Solheim BG; Akerblom O; Messeter L; James V; Bruce M; O'Riordan J; Murphy W; Schönitzer D; Mayr WR; Henn G; L'Herminez PC; Kühnl P; Kluge A; Mozzi F; Rebulla F; Sirchia P; Carbonell-Uberos F; Medgyesi G; Pisacka M; Letowska M; Gustafson M; Ganz P; Rees JW; Décary F; Wendel S; Rodrigues Almeida PT; Lin CK; Tadokoro K
    Vox Sang; 2000; 79(4):253-64. PubMed ID: 11206090
    [No Abstract]   [Full Text] [Related]  

  • 8. Transposing the E. E. U. Blood Directive into national law. Perspective of Slovenia.
    Potocnik M
    Transfus Clin Biol; 2005 Feb; 12(1):21-4. PubMed ID: 15814288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality assurance in transfusion medicine: organization of a quality assurance system exemplified by the Heidelberg University Blood Bank].
    Stahl D; Kluge A; Roelcke D
    Beitr Infusionsther Transfusionsmed; 1996; 33():247-56. PubMed ID: 8974702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The French Haemovigilance System: organization and results for 2003.
    Rebibo D; Hauser L; Slimani A; Hervé P; Andreu G
    Transfus Apher Sci; 2004 Oct; 31(2):145-53. PubMed ID: 15501418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood bank regulations in India.
    Choudhury N; Desai P
    Clin Lab Med; 2012 Jun; 32(2):293-9. PubMed ID: 22727006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemovigilance systems.
    Engelfriet CP; Reesink HW; Brand B; Lévy G; Williamson LM; Menitove JE; Heier HE; Jørgensen J; Politis C; Seyfried H; Smit Sibinga CT; Faber JC; Vesga MA; Selivanov E; Danilova T; Tadokoro K; Krusius T; Hafner V; Snopek I; Reali G; d'Almeida Gonçalves J
    Vox Sang; 1999; 77(2):110-20. PubMed ID: 10577259
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transfusion medicine in unified Europe].
    Grigutsch V
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():12-5. PubMed ID: 7841774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organisation of blood transfusion services.
    Hewitt PE; Regan FA
    Br J Hosp Med; 1995 Oct 18-31; 54(8):383-6. PubMed ID: 8535589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality management in European screening laboratories in blood establishments: A view of current approaches and trends.
    Pereira P; Westgard JO; Encarnação P; Seghatchian J; de Sousa G
    Transfus Apher Sci; 2015 Apr; 52(2):245-51. PubMed ID: 25765135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood & politics.
    Titus K
    CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
    [No Abstract]   [Full Text] [Related]  

  • 19. The regulatory pendulum in transfusion medicine.
    Farrugia A
    Transfus Med Rev; 2002 Oct; 16(4):273-82. PubMed ID: 12415513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of the implementation of the hemovigilance and transfusion safety system in French hospitals and blood transfusion centers].
    Fialon P; Quaranta JF; Lemonnier MP; Bricard H; Nublat M; Laxenaire MC; Blanloeil Y; Galperine I; Baron JF; Gross S; Fournel JJ; Vezon G; Janvier G
    Transfus Clin Biol; 1998 Jun; 5(3):193-202. PubMed ID: 9691363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.